home All News open_in_new Full Article

UE aprobă vaccinul Pfizer împotriva RSV pentru adulții cu risc crescut

Comisia Europeană a aprobat vaccinul Pfizer împotriva virusului respirator sincitial (RSV) pentru adulții cu risc crescut, cu vârste între 18 și 59 de ani, a anunțat compania marți. Vaccinul previne afecțiunile tractului respirator inferior cauzate de RSV, potrivit Reuters.


today 28 h. ago attach_file Events

attach_file Science
attach_file Economics
attach_file Economics
attach_file Science
attach_file Events
attach_file Economics
attach_file Science
attach_file Science
attach_file Politics
attach_file Events
attach_file Science
attach_file Culture
attach_file Events
attach_file Events
attach_file Science
attach_file Events
attach_file Economics
attach_file Politics
attach_file Science
attach_file Science


ID: 3959077015
Add Watch Country

arrow_drop_down